Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS … SK Sandur, MK Pandey, B Sung, KS Ahn, A Murakami, G Sethi, ... Carcinogenesis 28 (8), 1765-1773, 2007 | 851 | 2007 |
The role of resveratrol in cancer therapy JH Ko, G Sethi, JY Um, MK Shanmugam, F Arfuso, AP Kumar, A Bishayee, ... International journal of molecular sciences 18 (12), 2589, 2017 | 759 | 2017 |
Transcription factor NF‐κB: a sensor for smoke and stress signals KS Ahn, BB Aggarwal Annals of the new York Academy of Sciences 1056 (1), 218-233, 2005 | 600 | 2005 |
Targeting signal‐transducer‐and‐activator‐of‐transcription‐3 for prevention and therapy of cancer: modern target but ancient solution BB Aggarwal, G Sethi, KS Ahn, SK Sandur, MK Pandey, ... Annals of the New York Academy of Sciences 1091 (1), 151-169, 2006 | 547 | 2006 |
Natural products as a gold mine for arthritis treatment D Khanna, G Sethi, KS Ahn, MK Pandey, AB Kunnumakkara, B Sung, ... Current opinion in pharmacology 7 (3), 344-351, 2007 | 512 | 2007 |
β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation KR Park, D Nam, HM Yun, SG Lee, HJ Jang, G Sethi, SK Cho, KS Ahn Cancer letters 312 (2), 178-188, 2011 | 419 | 2011 |
Targeting nuclear factor-κB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis G Sethi, KS Ahn, BB Aggarwal Molecular cancer research 6 (6), 1059-1070, 2008 | 418 | 2008 |
Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and IκBα kinase activation, leading … SK Sandur, H Ichikawa, G Sethi, KS Ahn, BB Aggarwal Journal of Biological Chemistry 281 (25), 17023-17033, 2006 | 396 | 2006 |
Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-κB–regulated gene products and TAK1-mediated NF-κB … G Sethi, KS Ahn, MK Pandey, BB Aggarwal Blood 109 (7), 2727-2735, 2007 | 384 | 2007 |
Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells KS Ahn, EJ Noh, HL Zhao, SH Jung, SS Kang, YS Kim Life sciences 76 (20), 2315-2328, 2005 | 374 | 2005 |
Potential role of signal transducer and activator of transcription (STAT) 3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma A Subramaniam, MK Shanmugam, E Perumal, F Li, A Nachiyappan, X Dai, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1835 (1), 46-60, 2013 | 363 | 2013 |
γ-Tocotrienol inhibits nuclear factor-κB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and … KS Ahn, G Sethi, K Krishnan, BB Aggarwal Journal of Biological Chemistry 282 (1), 809-820, 2007 | 342 | 2007 |
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB–regulated gene products involved in cell … B Sung, MK Pandey, KS Ahn, T Yi, MM Chaturvedi, M Liu, BB Aggarwal Blood, The Journal of the American Society of Hematology 111 (10), 4880-4891, 2008 | 318 | 2008 |
Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway MK Pandey, B Sung, KS Ahn, AB Kunnumakkara, MM Chaturvedi, ... Blood, The Journal of the American Society of Hematology 110 (10), 3517-3525, 2007 | 310 | 2007 |
Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells AK Pathak, M Bhutani, AS Nair, KS Ahn, A Chakraborty, H Kadara, ... Molecular cancer research 5 (9), 943-955, 2007 | 309 | 2007 |
Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer D Shrimali, MK Shanmugam, AP Kumar, J Zhang, BKH Tan, KS Ahn, ... Cancer letters 341 (2), 139-149, 2013 | 303 | 2013 |
Targeting transcription factor STAT3 for cancer prevention and therapy EZP Chai, MK Shanmugam, F Arfuso, A Dharmarajan, C Wang, AP Kumar, ... Pharmacology & therapeutics 162, 86-97, 2016 | 287 | 2016 |
Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds MK Shanmugam, JH Lee, EZP Chai, MM Kanchi, S Kar, F Arfuso, ... Seminars in cancer biology 40, 35-47, 2016 | 246 | 2016 |
10 Curcumin—biological and medicinal properties BB Aggarwal, ID Bhatt, H Ichikawa, KS Ahn, G Sethi, SK Sandur, ... Indsaff, Inc., 2006 | 246 | 2006 |
NF-κB in cancer therapy F Li, J Zhang, F Arfuso, A Chinnathambi, ME Zayed, SA Alharbi, ... Archives of toxicology 89, 711-731, 2015 | 220 | 2015 |